← European Medicine Shortage Tracker · all medicines
Daptomicina currently has availability issues reported in 2 European registers: Greece, Italy.
Shortage ATC J01XX09 · also listed as: DAPTOMYCIN · DAPTOMICINA · data refreshed 7 August 2026
As of 7 August 2026, 2 of the 10 tracked registers list current availability issues for Daptomicina, covering 4 affected product presentations. The longest-running open report was filed in Italy on 2026-05-31 and has now been open for about 3 months. Where agencies state a cause, delivery delays lead with 2 of the 4 stated-cause reports, followed by commercial decisions or discontinuation with 1. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Greece, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Daptomicina is coded J01XX09 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability ZOLBIFEN PD.I.S.INF 350MG/VIAL BTx1 VIALx20 ML + 1 more productsZOLBIFEN PD.I.S.INF 500MG/VIAL BTx1 VIALx20 ML | 2026-06-15 | 2026-07-27 | VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητας Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
| 🇮🇹 Italy | Shortage CUBICIN + 1 more productsDAPTOMICINA DR. REDDY'S | 2026-05-31 | — | Cessata commercializzazione definitiva Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Daptomicina in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | CUBICIN | Shortage | 2026-12-31 | — | Cessata commercializzazione definitiva |
| 🇬🇷 GR | ZOLBIFEN PD.I.S.INF 500MG/VIAL BTx1 VIALx20 ML | Limited availability | 2026-06-26 | 2026-07-27 | VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητ |
| 🇬🇷 GR | ZOLBIFEN PD.I.S.INF 350MG/VIAL BTx1 VIALx20 ML | Limited availability | 2026-06-15 | 2026-07-06 | VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητ |
| 🇮🇹 IT | DAPTOMICINA DR. REDDY'S | Shortage | 2026-05-31 | — | Elevata richiesta |
Yes. As of 7 August 2026, availability issues are reported in: Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Daptomicina: EOF limited-availability list (Greece), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Daptomicina — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/daptomicina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Daptomicina availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/daptomicina/">Daptomicina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>